Caris Life Sciences, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 36.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.21B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Details
| Name | Caris Life Sciences, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 1846 |
| Founded | 2008 |
| Ipo Date | 2025-06-18 |
| Ceo | David Halbert |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 21.00 |
| Isin | US1421521071 |
| Cusip | 142152107 |
| Cik | 2019410 |
| Sic | 8071 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. David Dean Halbert M.D. | Chairman, Chief Executive Officer and Founder |
| Brian J. Brille J.D. | Executive Vice Chairman and Executive Vice President |
| Dr. David Spetzler M.B.A., M.S., Ph.D. | President |
| J. Russel Denton | Senior Vice President, General Counsel and Secretary |
| Luke Power | Senior Vice President, Chief Financial Officer and Chief Accounting Officer |
| Jon Mark Harmon | Senior Vice President and Chief Operations Officer |
Contact
| Address | 750 West John Carpenter Freeway, Suite 800, Irving, Texas 75039, United States |
| Phone | 866 771 8946 |
| Website | https://www.carislifesciences.com |